The Valley Desk

Clinical trial reportJournal of cystic fibrosis : official journal of the European Cystic Fibrosis SocietyPublished

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published
Subject terms
Humans; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; RNA, Messenger; Double-Blind Method; Mutation; Adult; Respiratory Aerosols and Droplets; Gene therapy; Aerosol; Mrna Therapy
PubMed ID
37121795
PubMed Central ID
PMC10524666
Added to directory
Source checked

Report a correction or request removal